Blossom Health, a NYC-based provider of an AI operating system for psychiatry, raised $20M in Series A and Seed funding

Blossom Health has raised $20 million in seed and Series A funding to scale its AI-powered psychiatry platform nationwide. The round was led by Headline with participation from Village Global, TA Ventures, Operator Partners and Correlation Ventures. The New York–based startup positions itself as an AI-native psychiatry platform, using AI agents to maintain continuous patient contact between visits and automate administrative tasks like billing and scheduling. Most patients are seen within 48 hours, often same-day. Blossom currently operates across nine states with over 100 clinicians treating more than 10,000 patients. Founder and CEO John Zhao, who previously worked at Athelas and EverQuote, said the platform offers in-network coverage with major insurers, with average copays around $22. The company plans to expand geographically and deepen payer relationships.